BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
-3.65%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-5.5%)
Cap. Flow
-$3.12M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
70.91%
Holding
50
New
–
Increased
8
Reduced
30
Closed
2
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$173K |
| 2 |
Microsoft
MSFT
|
$111K |
| 3 |
Five Below
FIVE
|
$102K |
| 4 |
Walt Disney
DIS
|
$90.2K |
| 5 |
Advanced Micro Devices
AMD
|
$56.9K |
Top Sells
| 1 |
Apple
AAPL
|
$744K |
| 2 |
Intuitive Surgical
ISRG
|
$295K |
| 3 |
Target
TGT
|
$212K |
| 4 |
Duke Energy
DUK
|
$206K |
| 5 |
AstraZeneca
AZN
|
$202K |
Sector Composition
| 1 | Technology | 42.42% |
| 2 | Consumer Discretionary | 26.33% |
| 3 | Healthcare | 18.9% |
| 4 | Communication Services | 10.6% |
| 5 | Utilities | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$374B
| $1.92M | 0.56% |
12,884
-731
| -5% | -$109K |
|
|
27
Palo Alto Networks
PANW
$128B
| $1.64M | 0.48% |
6,982
+740
| +12% | +$173K |
|
28
Bristol-Myers Squibb
BMY
$96.4B
| $1.61M | 0.47% |
27,697
-600
| -2% | -$34.8K |
|
29
Costco
COST
$416B
| $978K | 0.29% |
1,731
-60
| -3% | -$33.9K |
|
30
Johnson & Johnson
JNJ
$429B
| $732K | 0.21% |
4,701
-408
| -8% | -$63.5K |
|
31
Merck
MRK
$212B
| $717K | 0.21% |
6,966
-550
| -7% | -$56.6K |
|
32
Abbott
ABT
$228B
| $709K | 0.21% |
7,316
-825
| -10% | -$79.9K |
|
33
Paychex
PAYX
$49B
| $623K | 0.18% |
5,405
-300
| -5% | -$34.6K |
|
34
JPMorgan Chase
JPM
$821B
| $517K | 0.15% |
3,566
| – | – |
|
35
Boeing
BA
$180B
| $510K | 0.15% |
2,659
-30
| -1% | -$5.75K |
|
36
Deere & Co
DE
$128B
| $506K | 0.15% |
1,340
-16
| -1% | -$6.04K |
|
37
Nucor
NUE
$33.6B
| $503K | 0.15% |
3,220
-40
| -1% | -$6.25K |
|
38
UroGen Pharma
URGN
$890M
| $486K | 0.14% |
34,701
| – | – |
|
39
BioCryst Pharmaceuticals
BCRX
$1.76B
| $401K | 0.12% |
56,600
-12,000
| -17% | -$85K |
|
40
Caterpillar
CAT
$194B
| $388K | 0.11% |
1,422
| – | – |
|
41
Pfizer
PFE
$141B
| $276K | 0.08% |
8,310
-5,875
| -41% | -$195K |
|
42
Visa
V
$678B
| $258K | 0.08% |
1,120
| – | – |
|
43
Oracle
ORCL
$629B
| $253K | 0.07% |
2,389
| – | – |
|
44
Evolus
EOLS
$486M
| $229K | 0.07% |
25,070
| – | – |
|
45
Idexx Laboratories
IDXX
$51.2B
| $201K | 0.06% |
460
| – | – |
|
46
Summit Therapeutics
SMMT
$17.6B
| $45K | 0.01% |
24,059
| – | – |
|
47
Pulse Biosciences
PLSE
$1.03B
| $41.6K | 0.01% |
10,325
| – | – |
|
|
CMRX
48
DELISTED
Chimerix, Inc.
CMRX
| $10.2K | ﹤0.01% |
10,609
| – | – |
|
|
49
Duke Energy
DUK
$94.7B
| – | – |
-2,290
| Closed | -$206K |
|
|
50
Target
TGT
$42B
| – | – |
-1,605
| Closed | -$212K |
|